Literature DB >> 18198623

[Cross-sectional study of drug use in pregnancy].

Josip Culig1, Marcel Leppée, Danijela Stimac, Ivan Kuvacić, Tajana Pulanić-Klepac, Radoslav Herman, Neven Tuckar, Mario Podobnik, Ante Klobucar, Sanja Matesa, Marina Polić-Vizintin, Andrija-Miso Damić.   

Abstract

The aim of the paper is to investigate the impact of drugs utilization during pregnancy in the City of Zagreb. This one-month cross-sectional study was conducted in all four Zagreb maternity hospitals using a questionnaire administered to 893 pregnant women. The women used a mean of 2.6 drugs. The vitamin-mineral complex was the leading medicament used by the women during the study period (62.9%) and during pregnancy period. The leading drugs taken between hospital admission and delivery were metoclopramide (10.1%) and diazepam (6.0%). Utilization of diazepam is high during the entire pregnancy. According to FDA risk classification during pregnancy, most drugs are in B class (88%), and in A class (77%). Percent of FDA C class is 16%. In the FDA classes with fetal risk, D class has 47.5%, and X class, with only one woman using drug from this class has a 0.1% of total utilization. In spite of some limitations of the study, the results pointed to the uneconomical, potentially harmful drug use during pregnancy and puerperium, obviously calling for therapy quality upgrading in this vulnerable period of life.

Entities:  

Mesh:

Year:  2007        PMID: 18198623

Source DB:  PubMed          Journal:  Lijec Vjesn        ISSN: 0024-3477


  1 in total

1.  Clinical pharmacology consultation: a better answer to safety issues of drug therapy during pregnancy?

Authors:  Viktorija Erdeljić; Igor Francetić; Ksenija Makar-Ausperger; Robert Likić; Matea Radacić-Aumiler
Journal:  Eur J Clin Pharmacol       Date:  2010-07-20       Impact factor: 3.064

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.